Vitiligo type and distribution
Localized, segmental, non-segmental, generalized or mixed pattern is documented with body areas involved.
← Specialist review & coordination areas
Dermatology evaluation
Vitiligo Specialist Review & Care Coordination
A dermatology-focused file review for vitiligo, organized around lesion pattern, progression, previous therapy, medical background, expectations and whether a Cuba-related topical treatment discussion is clinically appropriate.
Medical disclaimer: This page is for information and international coordination only. It does not diagnose, prescribe, guarantee suitability or replace urgent local medical care.
Clinical file logic
01
02
03
04
05
06
The evaluation starts with diagnosis pattern and treatment history.
Vitiligo is not reviewed only by the name of the condition. The physician needs to know where lesions are located, how fast they are changing, whether the disease is stable or active, what has already been tried and whether autoimmune or thyroid context is relevant. The page is designed to prepare a clear dermatology file before any treatment or travel decision.
Stability and progression
Start date, recent spread, new lesions, Koebner phenomenon and progression speed are summarized.
Photo documentation
Clear daylight photos without filters help show lesion borders, body area, skin tone context and response over time.
Previous treatment response
Topical corticosteroids, calcineurin inhibitors, phototherapy, systemic therapy or other approaches are listed with dates and results.
Medical background
Thyroid disease, autoimmune conditions, pregnancy status, medications, allergies and sensitive areas are reviewed.
Patient goal and priority areas
Cosmetic and functional concerns are documented realistically, without guaranteeing repigmentation.
Review framework
What changes the next step.
The page is intentionally structured around clinical decision factors, not around promotional claims. The aim is to make the file safer, clearer and easier to review.
Stability affects expectations
Rapidly spreading disease, stable patches and long-standing depigmentation may require different discussion and timelines.
Photos must be clinically useful
Filtered, distant or poorly lit photos can mislead review; structured photos reduce unnecessary delay.
Treatment context is not universal
Melagenina Plus® or other topical contexts must be reviewed according to diagnosis pattern and physician judgment.
Local dermatology remains important
The patient should continue local dermatology care for diagnosis confirmation and monitoring when needed.
Documents to prepare
A complete file creates a better written response.
A dermatology review depends heavily on clear visual documentation and previous treatment history. The file should be practical, dated and realistic.
Diagnosis detailsVitiligo type, start date, progression pattern and affected body areas.
Clinical photosClear daylight photos from several angles without filters or heavy makeup.
Previous therapiesTopical treatments, phototherapy, systemic therapy or alternative options and response.
Medical backgroundThyroid or autoimmune history, pregnancy status, allergies and current medications.
Dermatology notesLocal diagnosis, biopsy if performed and specialist recommendations.
ExpectationsPriority areas, cosmetic concerns and realistic treatment objectives.
Cuba context
How the treatment discussion is framed responsibly.
The page does not present a procedure or travel plan as automatically suitable. Any Cuba-related discussion remains conditional on physician review of the current file.
Local medical care remains the baseline
The patient should continue appropriate local care while the file is being organized, especially when symptoms are active or worsening.
Named options are not presented as guarantees
Treatment names may be part of the medical context, but suitability, contraindications, dosing and monitoring must be determined by physicians.
Travel is not the first decision
The first decision is whether the file is complete enough for a responsible written response. Logistics come only after clinical clarity.
Options discussed in Cuba
Melagenina Plus in vitiligo: what is known and what is not
The points below are not promotional; they are what should be known before deciding.
Melagenina Plus was developed in Cuba by Dr Carlos Manuel Miyares Cao and is a topical lotion containing human placental extract and calcium chloride. The proposed effect is stimulation of melanocytes in healthy skin around depigmented areas, encouraging proliferation and melanin production. According to the approved product information it is applied by rubbing onto the depigmented areas once daily, at 24-hour intervals, and without exposure to an infrared lamp or sunlight.
The developing centre and treating clinics report high response rates, based largely on single-centre clinical series. These figures are presented as centre-reported data; the response expected in your case is discussed by the physician after assessing the sites involved and the course of the disease.
Better-defined options exist in vitiligo: topical corticosteroids, calcineurin inhibitors, narrowband UVB phototherapy and, in selected stable cases, surgical melanocyte transfer. A responsible plan includes whether those have been considered for this patient. The product is also not sold in Turkey; access runs through authorised centres in Cuba and the official application process.
Response varies by site
Face and trunk tend to respond better; fingers, backs of hands and the area around the lips are the most resistant. Expectations should be discussed site by site.
Disease activity first
Where patches have spread quickly in recent months, halting activity comes first; repigmentation achieved during active disease may not last.
Confirm the diagnosis
Other causes of depigmentation can resemble vitiligo. No treatment should be planned before a dermatological diagnosis is confirmed.
When local care comes first
Do not wait for international review if urgent symptoms are present.
International coordination should never delay emergency or necessary local care. If any of the following are present, the patient should be assessed locally first.
- Rapidly inflamed, painful, infected or blistering skin lesions.
- Severe allergic reaction, extensive rash after a treatment option or medication, or facial/eye swelling.
- Pregnancy, immunosuppression or complex autoimmune disease requiring local physician guidance before any new therapy.
Coordination pathway
From records to written next steps.
- File intakeReports, photos, laboratory results and current symptoms are uploaded through the application flow.
- Quality checkThe coordination team checks readability, dates, translation needs and missing items before routing the case.
- Specialist routingThe case is prepared around a clear medical question and sent through the relevant review pathway.
- Written responseThe patient receives organized next steps before travel, payment or treatment logistics are considered.
Questions
Before starting the application.
Does this page guarantee repigmentation?
No. Repigmentation cannot be guaranteed. The page only explains how the file is prepared for a responsible dermatology review.
Are photos enough for evaluation?
Photos are important, but diagnosis details, progression, previous treatment and medical background are also needed.
Can I use several vitiligo treatment options together?
Treatment options should not be combined without physician guidance. Some combinations may irritate skin or interfere with assessment.
Is Melagenina Plus® automatically suitable?
No. Any Cuba-related topical context must be reviewed according to the patient’s condition and physician judgment.
What does the written response include?
It should explain what was reviewed, what is missing and what next step is reasonable before travel or treatment logistics.
Related evaluation pages
Other specialty files reviewed through the same clinical coordination approach.
Official product information
Melagenina Plus as licensed in Cuba
The data below are taken from the product summary approved by CECMED, the Cuban medicines regulator. They describe the product as licensed in Cuba and are not a treatment recommendation.
- Composition
- Each 100 mL contains 50% alcoholic extract of human placenta and 100 mg calcium chloride.
- Approved indications
- Treatment of vitiligo, and depigmentation of the skin caused by burns of any origin.
- Route and schedule
- Applied by rubbing with the fingers onto the depigmented areas until the patch is covered — once daily, at 24-hour intervals, and without exposure to an infrared lamp or to sunlight.
- Contraindications
- Corticosteroids and psoralens interfere with the effect of the product. Eruptive skin diseases or other dermatological conditions. Other medicines or treatments indicated for vitiligo.
- Interactions
- Antagonistic interactions with corticosteroids, psoralens and immunosuppressants.
- Reported effects
- In some cases skin rash, itching, local irritation, redness and burning at the site of application.
Approval in Cuba does not mean approval in your country, and it does not mean the product is suitable for you. Eligibility is decided by the physician who reviews your complete file.
Start with the file
Submit documents before making a travel or treatment decision.
A coordinator will organize the medical information and guide the next step according to specialist review. The process is designed to be transparent, clinically cautious and written.